This test is most useful if any of these apply to you.
Maybe you or your child reacted after eating cashews. Maybe a blood test flagged cashew as positive and nobody could tell you what that meant. Ana o 1 IgE is one of the component tests that can help clarify the result. It looks for allergy antibodies to one defined cashew storage protein, and in children with suspected cashew allergy, higher levels tracked with reactions during supervised cashew challenges.
With cashew, that distinction matters. Tiny amounts can set off serious reactions, and cashew is a growing cause of anaphylaxis in children. A standard whole-cashew blood test, meanwhile, often comes back positive in people who eat cashews with no trouble at all.
IgE is the antibody type behind immediate allergic reactions like hives, swelling, vomiting, and anaphylaxis. Your immune system can start making it after learning to treat a food as a threat. Allergists call that sensitization. This test measures how much IgE in your blood is aimed at one specific cashew protein.
Cashews store three main proteins that feed the seedling when it sprouts: Ana o 1, Ana o 2, and Ana o 3. Ana o 1 belongs to a protein family called vicilins. Whole-nut extract contains many proteins at once. Component tests ask a narrower question: whether your IgE is aimed at a storage protein more closely tied to true cashew allergy.
Results are reported in kU/L, the standard unit for antibodies against one specific allergen. Read your level as a sliding scale of likelihood. A plain positive or negative label throws much of that information away. Because different lab platforms are not interchangeable, raw numbers from different systems should not be treated as the same result.
The test measures the antibody, and whether you'll react to eating cashew is a separate question. Your level shifts the odds of reacting but doesn't answer that question on its own.
The strongest Ana o 1 evidence comes from a Dutch multicenter study of 173 children with suspected cashew allergy. The children had a double-blind, placebo-controlled cashew challenge. They ate rising doses of cashew or a disguised placebo under supervision, and neither the child nor the clinical team knew which one was being given.
Ana o 1 separated allergic children from tolerant ones well. If you pick one allergic child and one tolerant child at random, the child with the higher Ana o 1 level was the allergic one about 87% of the time, a concordance score of 0.87. The chance of reacting climbed as levels rose. Ana o 1 still added information after the researchers accounted for each child's history, skin prick test, and whole-cashew IgE.
In the same children, Ana o 2 and Ana o 3 performed about as well, and all three did better than the whole-cashew test. Other research shows the same pattern. In a Swedish birth cohort, tree nut sensitization was often symptom-free, and storage-protein sensitization matched real symptoms better than whole-nut sensitization did.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 173 Dutch children with suspected cashew allergy | Ana o 1 antibody level against the outcome of a supervised cashew challenge | The chance of reacting rose steadily with level, and children at the highest levels were much more likely to react |
| Pooled studies of cashew allergy diagnosis | Antibody to Ana o 3, a related cashew protein, against confirmed allergy | It caught about 96 of 100 allergic people and correctly cleared about 94 of 100 tolerant ones |
| 2,215 Swedish young adults with blood and symptom data from a 4,089-person birth cohort | Tree nut storage-protein antibodies against whole-nut antibodies | Storage-protein antibodies matched real symptoms better, while whole-nut positives were often symptom-free |
Sources: van der Valk et al. 2017; Riggioni et al. 2023; Bager et al. 2021.
What this means for you: if you've had a believable reaction and your Ana o 1 level is high, cashew allergy is very likely. If you've never reacted and your level is low, the odds lean toward tolerance. The Ana o 1 study enrolled children, so its numbers describe children. Adults should treat the result as supporting evidence alongside their own history.
Two findings can look like they conflict. Many people carry cashew antibodies and eat cashews without trouble. A negative blood result also doesn't overrule a convincing immediate reaction. Both make sense once you treat the test as a probability tool. The antibody level shifts the odds, and your history settles much of the question, backed by a supervised challenge when needed.
Whole-cashew IgE catches many possible allergies but creates false alarms. It picks up antibodies to a mixture of cashew proteins, so a positive result is less specific than a component result. A negative can be reassuring in the right setting, but a positive does not prove allergy by itself.
Ana o 3 is the most-researched cashew component, and it's the one most labs and diagnostic algorithms use. Across pooled studies it caught about 96 of 100 allergic people and correctly cleared about 94 of 100 tolerant ones. Some approaches start with whole-cashew IgE and add Ana o 3 as a second step. In an Australian population study of children, that two-step approach improved accuracy and substantially reduced the number of children who needed a food challenge compared with whole-cashew IgE alone.
Ana o 1 is best read as a supporting component, not a standalone diagnosis. In many people the three cashew storage-protein antibodies rise together, so Ana o 1 often confirms what Ana o 3 already shows. It's most useful when results disagree or when you want a fuller picture of which cashew proteins your immune system targets.
Cashew is an allergen to take seriously. A European anaphylaxis registry found cashew among the most common confirmed tree nut triggers in children. A systematic review found that very small amounts can cause serious reactions, as with peanut and other tree nuts.
The evidence linking antibody patterns to severity is mostly about Ana o 3 and whole-cashew IgE, not Ana o 1. Children sensitized only to Ana o 3 had about 15 times the odds of severe anaphylaxis involving the heart or breathing. In children with several food allergies, higher Ana o 3 went along with gut reactions during challenges. In a study of 293 people who reacted to cashew during challenges, higher sensitization and pistachio allergy were linked to reacting at smaller doses.
What this means for you: no antibody level reliably predicts how bad your next reaction will be. Some studies find the basophil activation test relates better to challenge severity than antibody levels do. That test measures how readily your allergy cells react to cashew in a lab dish. If you have a real reaction history, the history matters more than a modest component result. Carry epinephrine when prescribed and get a full allergy workup.
Cashew and pistachio come from the same plant family, and their storage proteins are similar enough that IgE cross-reactivity is common. In one French series, nearly a third of cashew-allergic children were also allergic to pistachio. A small early report found that pistachio allergens are also present in cashew and mango seed, but not in mango flesh.
Peanut is a separate case, because peanut is a legume. In a Finnish study of 102 peanut-sensitized people evaluated with peanut challenge, sensitization to tree nut storage proteins was uncommon. Component testing can help decide which nuts deserve careful introduction or supervised challenge.
Most of the confusion comes from comparing numbers across labs, though a few medications matter too.
Antibody levels aren't fixed, especially in young children. In a Canadian birth cohort, about a quarter of children sensitized to key 2S storage proteins, including Ana o 3, lost that sensitization by age 5. That study looked at a related storage-protein family, so Ana o 1 may not follow the same pattern.
Get a baseline when the question first comes up. For a child with a cashew diagnosis, retest every 1 to 2 years, or sooner if the result may change a decision about a supervised challenge. If you're in a desensitization program, retesting at 3 to 6 months and then at least yearly is common. Published cashew treatment studies mostly track whole-cashew IgE and Ana o 3, not Ana o 1 separately.
If you're an adult with a stable, convincing diagnosis, you usually don't need frequent retesting. Retest when your history changes, for example after a new reaction, if you've eaten cashew without a problem, or if you're deciding whether a supervised challenge or treatment program makes sense. Use the same lab each time so changes in the number reflect you and not the equipment.
Your result only means something next to your history, so read it as part of a pattern.
Decisions about treatment, from oral immunotherapy to anti-IgE injections, belong with an allergist. You can order and track the tests yourself, and having component results in hand can spare you a food challenge you turn out not to need.
Cashew (Ana o 1) IgE is best interpreted alongside these tests.
Cashew (Ana o 1) IgE is included in these pre-built panels.